AzTrials
AzTrials

Chronic SinusitisNCT03336671

Management of Pediatric Chronic Rhinosinusitis in Asthmatic Children

A study testing Endoscopic Sinus surgery and Adenoidectomy in people with Chronic Sinusitis and Adenoid Disease - Chronic, run by State University of New York - Upstate Medical University at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The objectives of this study would be to determine the most effective management for pediatric patients with chronic rhinosinusitis and asthma who fail medical management. The Sinus and Nasal Quality of Life Survey (SN-5), a validated tool, will be used to track symptoms of pediatric chronic rhinosinusitis. Read more about this study

Who is it for?
Ages 6 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Chronic Sinusitis, Adenoid Disease - Chronic
What is being tested?
Endoscopic Sinus surgery and Adenoidectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4 participants
Where
1 siteUnited States
Study dates
1 Jul 2017to 1 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Age 6-12 at time of study enrollment.
  • Presence of chronic sinusitis: >90 days 2 or more symptoms of purulent rhinorrhea, nasal obstruction, facial pressure/pain, or cough
  • Presence of asthma, as documented in the medical record by the patient's pediatrician and/or pulmonologist
  • Failure of medical management of pediatric chronic rhinosinusitis, which current guidelines recommend extended empiric antibiotics for 21 days, which will be either Augmentin or clindamycin in penicillin allergic patients, at standard pediatric weight based dosing. In addition, Flonase nasal spray and nasal saline treatment for three weeks. Failure is considered persistent symptoms despite treatment with the above within the past year.

Who cannot join

  • Previous sinus surgery,
  • Previous adenoidectomy, or
  • Presence of cystic fibrosis,
  • Presence of antrochoanal polyp,
  • Immunodeficiency
  • Fungal infection.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • SUNY Upstate Medical University

    Syracuse, New York, 13202

Other trials in United States

About this study

The objectives of this study would be to determine the most effective management for pediatric patients with chronic rhinosinusitis and asthma who fail medical management. The Sinus and Nasal Quality of Life Survey (SN-5), a validated tool, will be used to track symptoms of pediatric chronic rhinosinusitis. A decrease in at least 0.5 is felt to represent an improvement in symptom control. In this study, the SN-5 at one year post intervention will be the primary endpoint. Secondary endpoints include complications, revision surgery, and post operative endoscopy scores.

Read the detailed description

Indications for surgery for pediatric chronic rhinosinusitis currently lacks scientific consensus. In general, children who fail medical management are candidates for surgery. Currently, pre-operative evaluation with a CT scan of the sinuses is the gold standard prior to sinus surgery. However, the role of the adenoids and adenoiditis in pediatric chronic sinusitis is incompletely understood. Adenoids may contribute to sinusitis both as a bacterial reservoir and obstruct nasal secretion drainage, owing to their larger relative size in children. Adenoidectomy alone has been found to improve symptoms in 75% of children.

It has been found that 50% of children continued to be symptomatic after adenoidectomy, and went on to require endoscopic sinus surgery (ESS). In addition, of the group that failed, 58% had asthma. Overall, asthma and age have been the only known risk factors for failure of adenoidectomy.

Specific Objectives The objectives of this study would be to determine the most effective management for pediatric patients with chronic rhinosinusitis and asthma who fail medical management. Outcomes will be evaluated using the SN-5, a validated tool used to track symptoms of pediatric chronic rhinosinusitis. A decrease in at least 0.5 is felt to represent an improvement in symptom control. In this study, the SN-5 at one year post intervention will be the primary endpoint. Secondary endpoints include complications, revision surgery, and post operative endoscopy scores.

Study Design

The primary outcome is the SN-5 score one year post surgery. A change of 0.5-1.0 is considered a mild improvement, while a change of at least 1.0 is considered a moderate improvement.

Sixty patients are required to have an 80% chance of detecting, as significant at the 5% level, an increase in the primary outcome measure from 47% in the control group to 80% in the experimental group.

Statistical Methods:

Univariate statistical analysis using chi-square in analysis of binary outcomes. In addition paired t test of preoperative and postoperative SN-5 scores will be performed.

Data Analysis and Interpretation:

Analysis of SN-5, and comparison of Lund-McKay(CT) scores along with post operative endoscopy Kennedy scores.

Study Procedures:

The patient's will initially be seen as a referral to the otolaryngology clinic for symptoms including chronic rhinosinusitis. If they meet inclusion criteria, they will be offered enrollment into the study and consent will be obtained. Their symptoms will be followed at each visit with the SN-5, a validated symptom-scoring tool to evaluate pediatric chronic rhinosinusitis.

If the patient does not improve with medical therapy alone after review of the SN-5 and in discussion with caregivers, he or she will be offered entry into the study, with consent, CT scan of the sinuses, and will be randomized to two different treatment arms. The first is adenoidectomy. The patient will then be followed at defined intervals with evaluation of symptoms by SN-5. Should symptoms worsen or not improve, they will then be offered endoscopic sinus surgery, with findings from the CT scan of the sinuses to guide operative intervention. Adenoidectomy followed by endoscopic sinus surgery is the current standard of care and serves as the control arm. In the other experimental or study arm, the patient will undergo adenoidectomy with endoscopic sinus surgery at the same time. Radioallergosorbent test blood testing for allergies would be performed at the time of surgery in both groups.

For patients who initially improve with medical therapy, but relapse at a later time, they may either undergo consent and randomization if they relapse within a year or a repeat course of medical therapy if it has been one year since previous medical therapy.

Endoscopic sinus surgery, in both arms would be tailored to abnormal findings in the CT scan, as is the standard of care. Radiologists typically examine sinonasal disease of the sinuses, and they would also be requested to comment on the patency of the osteo-meatal unit, as this is a component of the Lund-McKay score. The Lund-McKay score is an objective radiologic grade of the severity of sinusitis. If there is sinus thickening, or narrowing of the osteomeatal unit, endoscopic sinus surgery would be tailored to this using either balloon sinus opening or traditional antrostomy. Patient undergoing endoscopic sinus surgery will likely have at least a maxillary antrostomy and anterior ethmoidectomy performed, with frontal sinusotomy, posterior ethmoidectomy, and sphenoidotomy performed depending on CT or endoscopy findings.

Being tested
Endoscopic Sinus surgery, Adenoidectomy
Keywords
Pediatric, Chronic Sinusitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endoscopic Sinus surgeryProcedure or surgery

    Also called Functional Endoscopic Sinus Surgery

    Endoscopic sinus surgery would be tailored to abnormal findings in the CT scan, as is the standard of care. Radiologists typically examine sinonasal disease of the sinuses, and they would also be requested to comment on the patency of the osteo-meatal unit, as this is a component of the Lund-McKay score. The Lund-McKay score is an objective radiologic grade of the severity of sinusitis. If there is sinus thickening, or narrowing of the OMU, endoscopic sinus surgery would be tailored to this using either balloon sinuplasty or traditional antrostomy. Patient undergoing endoscopic sinus surgery will likely have at least a maxillary antrostomy and anterior ethmoidectomy performed, with frontal sinusotomy, posterior ethmoidectomy, and sphenoidotomy performed depending on CT or endoscopy findings.

  • AdenoidectomyProcedure or surgery

    Adenoidectomy performed, routine, as a singular procedure not combined with any sinus surgery.

Study groups in NCT03336671
Study groupRoleWhat they receive
AdenoidectomyActive comparatorCurrent standard of care for pediatric chronic rhino sinusitis.
Receives: Procedure: Adenoidectomy
Adenoidectomy plus Endoscopic Sinus SurgeryExperimentalendoscopic sinus surgery in addition to adenoidectomy
Receives: Procedure: Endoscopic Sinus surgery; Procedure: Adenoidectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. SN-5 at one year post procedure

    A validated tool used to track symptoms of pediatric chronic rhinosinusitis, improvement greater than 0.5

    Measured: One year

Secondary outcomes (3)
  1. Revision/Alternate procedure, endoscopic sinus surgery

    Requirement of the alternate procedure or a revision procedure.

    Measured: Two Years

  2. Antibiotic use after surgical procedure

    Relapse of chronic rhinosinusitis, if treated with antibiotics will be documented as the number of courses of antibiotics taken for rhino sinusitis in two years after the initial procedure

    Measured: Two years

  3. Complication Rate

    Complications associated with medical management, or surgery

    Measured: Two Years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Nov 2017
  2. Study start1 Jul 2017
  3. Primary completion1 Jul 2020
  4. Study completion1 Jul 2020

Why it stopped: Poor recruitment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective Randomized Controlled Trial
Masking
None (open label)
Enrolment
4 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03336671
Sponsor's protocol ID
1009628
Status last verified
Oct 2021
First submitted
1 Nov 2017
Last updated
13 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Endoscopic Sinus surgery and Adenoidectomy in people with Chronic Sinusitis and Adenoid Disease - Chronic, run by State University of New York - Upstate Medical University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 13 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Poor recruitment). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

SN-5 at one year post procedure (time frame: One year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in